Gilead Sciences's total assets for Q4 2025 were $59.02B, an increase of 0.84% from the previous quarter. GILD total liabilities were $36.41B for the fiscal quarter, a -1.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.